- RecruitingPHASE2, PHASE3
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
This study is testing a new medicine called nipocalimab for adults with a nerve condition called CIDP. It wants to see if nipocalimab is safe and effective at stopping CIDP symptoms from returning, compared to a dummy medicine, after patients have improved on nipocalimab first.
For: Polyradiculoneuropathy, Chronic Inflammatory DemyelinatingUnited States · Argentina · Australia - RecruitingPHASE3
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
This study is looking at a new medicine called nipocalimab for adults with moderate to severe lupus. It compares nipocalimab to a dummy treatment (placebo) to see if it can help reduce inflammation and improve lupus symptoms.
For: Lupus Erythematosus, SystemicUnited States · Argentina · Brazil - RecruitingPHASE3
A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
This study looks at a new medicine called nipocalimab to help pregnant people whose babies are at risk of a serious blood condition called HDFN. It aims to see if the medicine can stop the baby from developing anaemia while still in the womb.
For: Hemolytic Disease of the Fetus and NewbornUnited States · Argentina · Australia - RecruitingPHASE3
A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
This study is looking at new ways to prevent a serious bleeding condition in babies called FNAIT. It compares a new medicine, nipocalimab, with standard treatments like IVIG, in pregnant women who have had FNAIT before. The aim is to find safer, more effective ways to protect newborns.
For: Thrombocytopenia, Neonatal AlloimmuneUnited States · Austria · Germany - Active not recruitingPHASE3
Nipocalimab in Moderate to Severe Sjogren's Disease
This study is testing a new drug called nipocalimab for people with moderate to severe Sjögren's disease. Researchers want to see if it's safe and effective compared to a dummy treatment (placebo) alongside their usual care.
For: Sjogrens SyndromeUnited States · Argentina · Austria - Active not recruitingPHASE2
A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies
This study is looking into a new medication called Nipocalimab for people with active inflammatory myopathies, a condition that causes muscle weakness and inflammation. It aims to see if Nipocalimab is safe and helps more than a dummy treatment.
For: MyositisUnited States · Canada · Czechia